Kestra Medical Technologies (NASDAQ: KMTS) insider files to sell 3,580 shares

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. (KMTS) has a proposed sale of 3,580 shares of common stock through Merrill Lynch on 08/04/2026, following the 07/17/2026 vesting of restricted stock unit awards granted as equity compensation. The Form 144 also lists prior sales over the last three months by reporting person Traci Umberger.

Key Figures

Shares proposed for sale: 3,580 shares Proposed aggregate market value: 86,073.05 Sale 1 shares and proceeds: 5,887 shares; 133,892.22 +3 more

6 metrics

Shares proposed for sale 3,580 shares Common stock to be sold through Merrill Lynch on 08/04/2026

Proposed aggregate market value 86,073.05 Value associated with 3,580 shares of common stock listed with Merrill Lynch

Sale 1 shares and proceeds 5,887 shares; 133,892.22 Common stock sold on 07/30/2026 by Traci Umberger

Sale 2 shares and proceeds 8,752 shares; 197,837.19 Common stock sold on 07/31/2026 by Traci Umberger

Sale 3 shares and proceeds 7,590 shares; 181,061.84 Common stock sold on 08/03/2026 by Traci Umberger

RSU vesting date 07/17/2026 Vesting date of restricted stock unit awards underlying 3,580 shares

Key Terms

Form 144, restricted stock unit, equity compensation

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock unit financial

"Vesting of restricted stock unit awards"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

equity compensation financial

"Granted as part of issuer equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 04:34 PM Accepted by SEC EDGAR 08/04/2026 - 04:33 PM Learn about SEC filing dates

FAQ

What does Kestra Medical Technologies (KMTS) report in this Form 144?

Kestra Medical Technologies reports a proposed sale of 3,580 shares of common stock by a shareholder, to be executed through Merrill Lynch on 08/04/2026, along with a record of recent share sales in the past three months.

How many KMTS shares are proposed to be sold and through which broker?

The filing notes a proposed sale of 3,580 KMTS common shares through Merrill Lynch, with the planned sale date of 08/04/2026, following the vesting of restricted stock units granted as equity compensation.

What is the origin of the KMTS shares covered by this Form 144?

The 3,580 shares covered by the Form 144 arise from the 07/17/2026 vesting of restricted stock unit awards that were granted as part of issuer equity compensation by Kestra Medical Technologies, Ltd.

What recent KMTS stock sales are disclosed for Traci Umberger?

The filing lists Traci Umberger’s sales of 5,887 shares on 07/30/2026 for $133,892.22, 8,752 shares on 07/31/2026 for $197,837.19, and 7,590 shares on 08/03/2026 for $181,061.84.

Is Kestra Medical Technologies (KMTS) itself selling stock in this Form 144?

No. The Form 144 describes a shareholder’s proposed sale of KMTS common stock, including shares received from vested restricted stock units, rather than a direct sale of shares by the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	3580	86073.05	58602497	08/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of restricted stock unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			3580	07/17/2026	Granted as part of issuer equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Traci Umberger 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/30/2026	5887	133892.22
Traci Umberger 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/31/2026	8752	197837.19
Traci Umberger 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	08/03/2026	7590	181061.84

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)